Skip to main content

Advertisement

ADVERTISEMENT

News

News
09/18/2022
In patients receiving vascular closure devices, ultrasound with fluoroscopic guidance did reduce vascular complications and bleeding.
In patients receiving vascular closure devices, ultrasound with fluoroscopic guidance did reduce vascular complications and bleeding.
In patients receiving vascular...
09/18/2022
Cath Lab Digest
News
09/18/2022
September 18, 2022 — PALO ALTO, Calif.- ReCor Medical, Inc., a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., today announced the detailed results from the RADIANCE II US FDA IDE pivotal trial evaluating the endovascular...
September 18, 2022 — PALO ALTO, Calif.- ReCor Medical, Inc., a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., today announced the detailed results from the RADIANCE II US FDA IDE pivotal trial evaluating the endovascular...
September 18, 2022 — PALO ALTO,...
09/18/2022
Cath Lab Digest
News
09/17/2022
An analysis from the Society of Thoracic Surgeons/American College of Cardiology (STS/ACC) TVT Registry found that most patients with severe mitral regurgitation (MR) and cardiogenic shock (CS) who underwent mitral transcatheter edge-to-edge...
An analysis from the Society of Thoracic Surgeons/American College of Cardiology (STS/ACC) TVT Registry found that most patients with severe mitral regurgitation (MR) and cardiogenic shock (CS) who underwent mitral transcatheter edge-to-edge...
An analysis from the Society of...
09/17/2022
Cath Lab Digest
News
09/17/2022
Five late-breaking presentations at TCT 2022 highlight the impact of Abbott's structural heart devices to repair or replace heart valves and close openings in the heart New data reinforce the safety and effectiveness of MitraClip™ for...
Five late-breaking presentations at TCT 2022 highlight the impact of Abbott's structural heart devices to repair or replace heart valves and close openings in the heart New data reinforce the safety and effectiveness of MitraClip™ for...
Five late-breaking...
09/17/2022
Cath Lab Digest
News
09/17/2022
Data show significantly reduced infarct size in STEMI patients who received left ventricular (LV) unloading with Impella CP for 30 minutes prior to their percutaneous coronary intervention (PCI).
Data show significantly reduced infarct size in STEMI patients who received left ventricular (LV) unloading with Impella CP for 30 minutes prior to their percutaneous coronary intervention (PCI).
Data show significantly reduced...
09/17/2022
Cath Lab Digest
News
09/17/2022
Edwards Lifesciences Corporation announced results from CLASP IID, the first randomized controlled trial that directly compares two contemporary transcatheter edge-to-edge repair (TEER) therapies.
Edwards Lifesciences Corporation announced results from CLASP IID, the first randomized controlled trial that directly compares two contemporary transcatheter edge-to-edge repair (TEER) therapies.
Edwards Lifesciences Corporation...
09/17/2022
Cath Lab Digest
News
09/17/2022
Boston Scientific Corporation announced results from the PROTECTED TAVR clinical trial evaluating the SENTINEL™ Cerebral Protection System, which is designed to capture and remove embolic debris stemming from transcatheter aortic valve...
Boston Scientific Corporation announced results from the PROTECTED TAVR clinical trial evaluating the SENTINEL™ Cerebral Protection System, which is designed to capture and remove embolic debris stemming from transcatheter aortic valve...
Boston Scientific Corporation...
09/17/2022
Cath Lab Digest
News
09/17/2022
A first-in-human (FIH) study using the ModulHeart device (Puzzle Medical Devices Inc.) has demonstrated significant improvement in cardiac output, left ventricular end diastolic pressure, and urine output in patients with heart failure or...
A first-in-human (FIH) study using the ModulHeart device (Puzzle Medical Devices Inc.) has demonstrated significant improvement in cardiac output, left ventricular end diastolic pressure, and urine output in patients with heart failure or...
A first-in-human (FIH) study...
09/17/2022
Cath Lab Digest
News
09/16/2022
Medtronic today announced the expanded U.S. market release of its newest-generation, self-expanding transcatheter aortic valve replacement (TAVR) system, the Evolut™ FX TAVR system.
Medtronic today announced the expanded U.S. market release of its newest-generation, self-expanding transcatheter aortic valve replacement (TAVR) system, the Evolut™ FX TAVR system.
Medtronic today announced the...
09/16/2022
Cath Lab Digest
News
09/16/2022
SANTA CLARA, CA – Sept. 16, 2022 – HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, announced that its...
SANTA CLARA, CA – Sept. 16, 2022 – HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, announced that its...
SANTA CLARA,...
09/16/2022
Cath Lab Digest

Advertisement

Advertisement

Advertisement